Processing Intergenerational Trauma With Psilocybin-Assisted Therapy
This is an open-label psilocybin-assisted therapy study that will examine the safety and tolerability of psilocybin-assisted therapy in the offspring of genocide survivors with mood and anxiety disorders. The study will also investigate the efficacy of psilocybin-assisted therapy in reducing symptoms such as depression, anxiety and stress, as well as changes to the psychological effects of parental exposure to genocide, and changes to psychological resilience.
- Status
- recruiting
- Phase
- Phase 2
- Institution
- Rachel Yehuda
- Principal investigator
- Rachel Yehuda, PhD
- Start date
- 2025-08-28
- End date
- 2030-01-02
- Registry ID
- NCT06899165
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.